Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
07/1996
07/04/1996WO1996020403A1 Assay, receptor proteins and ligands
07/04/1996WO1996020280A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use
07/04/1996WO1996020277A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
07/04/1996WO1996020219A2 Murine monoclonal anti-idiotype antibody 3h1
07/04/1996WO1996020211A1 Phosphotyrosine assay and peptides for use therein
07/04/1996CA2228723A1 Assay, receptor proteins and ligands
07/04/1996CA2208319A1 Assay, receptor proteins and ligands
07/04/1996CA2208318A1 Phosphotyrosine assay and peptides for use therein
07/04/1996CA2208291A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use
07/03/1996EP0719335A1 Hybrid toxin
07/03/1996EP0719330A1 Protocadherin proteins and their uses
07/03/1996EP0441955B1 Production of biologically active insulin-like growth factor i from high expression host cell systems
07/02/1996US5532347 DNA encoding α melanocyte stimulating hormone receptor
07/02/1996US5532169 Quantitating concentration of peptides in body fluids and collagen telopeptides with hydroxylysyl pyridoline crosslinking
06/1996
06/27/1996WO1996019584A1 Chimeric antibodies comprising antigen binding sites and b and t cell epitopes
06/27/1996WO1996019496A1 Variants of human papilloma virus antigens
06/27/1996CA2419289A1 Variants of human papilloma virus antigens
06/26/1996EP0718309A1 Antigens and antibodies for the detection of collagen I
06/25/1996US5530101 Humanized immunoglobulins
06/25/1996US5530094 Gamma retinoic acid receptor
06/25/1996US5529925 Isolated nucleic acid molecule having sequence encoding anaplastic lymphoma kinase protein contained in plasmid
06/25/1996US5529922 Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD3 and hybridoma producing said antibody
06/20/1996WO1996018412A1 Chimeric cytokines and uses thereof
06/20/1996CA2205572A1 Chimeric cytokines and uses thereof
06/19/1996EP0717109A1 Synthetic DNA derived recombinant HIV-2 antigens
06/19/1996EP0527778B1 Improved process of purifying recombinant proteins and compounds useful in such process
06/19/1996EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor
06/13/1996WO1996017942A1 Production of peptides using recombinant fusion protein constructs
06/13/1996CA2206848A1 Production of peptides using recombinant fusion protein constructs
06/12/1996EP0573552B1 Cultures of permanent lines of human promyelocyte cells, their use for screening molecules useful particularly in treating leukemias
06/12/1996EP0463151B1 Generation of xenogeneic antibodies
06/12/1996EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity
06/11/1996US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells
06/05/1996EP0714982A2 Hybrid proteins with fibrinolytic and thrombin inhibiting activity
06/05/1996EP0312542B1 Gamma, delta t cell receptor and methods for detection
06/04/1996CA2054551C Monoclonal antibodies to mite allergen and the use thereof
05/1996
05/31/1996CA2163925A1 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
05/30/1996WO1996016176A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
05/30/1996WO1996015810A1 Monofunctional and/or polyfunctional polylysine conjugates
05/30/1996CA2205807A1 Fusion proteins with cytotoxic activity against cells overexpressing erbb2-4
05/29/1996EP0713496A1 Fibrin-targeted inhibitors of thrombin
05/29/1996EP0713493A1 Production of human hemoglobin in transgenic pigs
05/29/1996EP0679089A4 Methods for promoting cartilage matrix formation.
05/29/1996EP0469065B1 Recombinant antibody-toxin fusion protein
05/28/1996US5521295 Nucleic acids encoding hybrid receptor molecules
05/28/1996US5521086 Secretion sequence for the production of a heterologous protein in yeast
05/28/1996US5521066 Periplasmic membrane-bound system for detecting protein-protein interactions
05/28/1996CA2078996C A bifunctional dtpa-type ligand
05/23/1996WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996WO1996015238A1 Targeted t lymphocytes
05/23/1996WO1996015149A2 Methods and compositions for screening for presynaptic calcium channel blockers
05/23/1996CA2206110A1 Methods and compositions for screening for presynaptic calcium channel blockers
05/23/1996CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996CA2203934A1 Targeted t lymphocytes
05/22/1996EP0712934A2 Proteins with fibrinolytic and anticoagulant activity
05/22/1996EP0712930A2 A transgenic nonhuman animal model for diabetes
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712863A1 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
05/22/1996EP0712414A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences
05/22/1996EP0486526B1 Tumour necrosis factor binding ligands
05/21/1996US5519115 Reverse antimicrobial peptides
05/21/1996US5518914 Growth medium containing a complex of prealbumin, a retinoid and retinol-binding protein used to enhance B cell growth
05/21/1996US5518723 Vaccines containing antibodies and epitopes
05/21/1996CA1338338C Process for the preparation of foreign proteins in streptomycetes
05/18/1996CA2162986A1 Proteins having fibrinolytic and coagulation-inhibiting properties
05/17/1996WO1996014411A1 Methods for the diagnosis of glaucoma
05/17/1996WO1996014339A1 Antibodies
05/15/1996EP0711345A1 B7-2: ctl a4/cd 28 counter receptor
05/15/1996EP0482013B1 Nonglycosylated human interleukin-3 analog proteins
05/14/1996US5516658 DNA encoding cytokines that bind the cell surface receptor hek
05/14/1996US5516637 Genetic engineering; expression
05/09/1996WO1996013599A1 Nucleic acid transfer system
05/09/1996WO1996013594A1 Tumor-specific antibody fragments, fusion proteins, and uses thereof
05/09/1996WO1996013583A2 Targeted hetero-association of recombinant proteins to multi-functional complexes
05/09/1996WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996CA2204020A1 Nucleic acid transfer system
05/09/1996CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996CA2203641A1 Bcl-x/bcl-2 associated cell death regulator
05/09/1996CA2203236A1 Tumor-specific antibody fragments, fusion proteins, and uses thereof
05/08/1996EP0710723A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica
05/08/1996EP0710719A1 Generation of xenogeneic antibodies
05/08/1996EP0710286A1 Methods and dna expression systems for over-expression of proteins in host cells
05/08/1996EP0365646B1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
05/07/1996US5514599 Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays
05/07/1996US5514585 Yeast processing system
05/07/1996US5514578 Genetic engineering
05/07/1996US5514559 Immunologically active conjugates and method for their preparation
05/07/1996CA1338320C Resorufin derivatives
05/07/1996CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
05/02/1996WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996WO1996012796A1 Conditional transformation of genetically engineered cells
05/02/1996CA2416318A1 Soluble, recombinant botulinum toxin proteins
05/02/1996CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/01/1996EP0709396A1 Gamma T cell receptor and methods for detection
05/01/1996EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
05/01/1996EP0491031B1 Cdr grafted anti-cea antibodies and their production
05/01/1996EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates
05/01/1996CN1031714C Process for preparing urinary follicle stimulating hormone
04/1996
04/30/1996US5512661 Provides for nucleic acids encoding chimeric neurotrophic factors; for targeting active compounds to cells responsive to neurotropic factor
04/30/1996US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids
1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 295